Shanghai UnionClin Co., Ltd (UnionClin), founded in 2017 and headquartered in Shanghai, focuses on the fields of Oncology, Autoimmune, Infectious Diseases, Neurology, and Cardiovascular Diseases, providing end-to-end integrated professional services for new drug clinical trials, including strategy consulting, regulatory affairs, medical affairs, clinical operations, data management and statistics, clinical pharmacology, pharmacovigilance, IRC service, bioanalysis, site management, and FSP services.

UnionClin has 500 employees across over 100 cities nationwide. The core team members have over 15 years of industry experience on average and have provided services for over 200 clinical trials of innovative drugs.

UnionClin has established effective cooperative relationships with over 2,000 highly influential clinical experts and over 700 research centers (including multiple national-level medical centers and clinical research entities such as the Department of Internal Medicine at Fudan University Shanghai Cancer Hospital, National Medical Center for Infectious Diseases, and National Medical Center for Cardiovascular Diseases) in the fields of oncology, autoimmune, infections, neurology, and cardiovascular diseases. Our clinical research network covers 28 provinces and municipalities and over 100 cities nationwide, which can quickly help clients match experts, centers, and patient pools.